Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Blockchain is resistant to hacking due to cryptographic proofs and distributed consensus, making attacks difficult and costly while preserving integrity.
17,795 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Regulators warn of a loophole that allows new chemicals to enter foods and supplements without premarket approval. Th...
The nobel laureate joseph stiglitz warns that AI’s hunger for internet chatter could degrade the data powering market...
A modest pullback has the market forecasting a renewed buy-the-dip phase as earnings beat, and credit conditions stab...
Gen Z is showing nostalgia for the early, chaotic days of TikTok even as the platform evolves into a commerce-focused...
As a new Fed leadership team takes the reins, investors are bracing for a steadier communications stance. Analysts sa...
Anthropic has filed a high-stakes lawsuit against the U.S. Department of War over DoD procurement actions, threatenin...
Traders are turning to a wheel-style IBIT options strategy that converts Bitcoin's volatility into premium. The appro...
A high-profile critique of a blockbuster series shines a light on how media can nudge spending habits. This article b...
Vanguard's dividend-growth ETF outpaced the Dividend Aristocrats ETF over the past decade, delivering higher returns ...
A major stake in Nvidia from a notable Tesla bull underscores confidence in the AI chip leader’s growth trajectory, e...
Citi upgraded AMD to Buy with a $575 price target, sending shares higher and reigniting the AI GPU narrative. Investo...